Subgroup analysis suggested that patients with large, localized tumors benefited from the addition of etoposide, whereas patients with metastases did not. There was no difference in EFS between ...

The combination of carboplatin and etoposide remains the standard first-line chemotherapy option for the treatment of patients with extensive-stage SCLC. SCLC accounts for 13% of all lung cancer ...

There are many cancer drugs and cancer drug combinations. They have individual side effects. The list includes chemotherapy, hormone therapies, targeted cancer drugs, immunotherapy drugs and ...

Metronomic chemotherapy is based on the chronic administration of chemotherapeutic agents at relatively low, minimally toxic doses, and with no prolonged drug-free breaks Metronomic chemotherapy ...

BEP is a combination chemotherapy treatment that healthcare ... Your doctor will explain your individual treatment cycles. Day 3 – etoposide is injected into your bloodstream Day 8 – bleomycin ...

EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer ...

Unlike conventional high-dose chemotherapy regimens, MC uses low-dose agents like cyclophosphamide and etoposide, often in combination with non-chemotherapeutic agents such as celecoxib and ...

BeiGene (ONC) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion ...